Table 2.
Comparison of patients according to dosage after which symptoms occurred
| Initial symptoms after <648.07 mg/m2 | Initial symptoms after ≥648.07 mg/m2 | ||
|---|---|---|---|
| n = 6 | n = 12 | p value | |
| Age, years (SD) | 63.17 ± 6.55 | 62.41 ± 9.24 | 0.86 |
| Female (%) | 5(83.33) | 7(58.33) | 0.29 |
| Initial pain level | 7.67 ± 0.51 | 7.17 ± 1.34 | 0.40 |
| Pain after 1 day, NRS | 5.50 ± 1.57 | 4.75 ± 1.36 | 0.30 |
| Pain after 8 days, NRS | 3.83 ± 1.47 | 2.25 ± 1.14 | 0.02 |
| Pain after 8 weeks, NRS | 2.50 ± 1.87 | 1.25 ± 1.29 | 0.11 |
| Pain after 12 weeks, NRS | 1.16 ± 1/32 | 0.25 ± 0.45 | 0.04 |
| Pain reduction after 1 day, % (SD) | 27.98 ± 19.74 | 33.44 ± 15.20 | 0.52 |
| Pain reduction after 8 days, % (SD) | 49.40 ± 20.34 | 69.55 ± 12.09 | 0.02 |
| Pain reduction after 8 weeks, % (SD) | 66.67 ± 24.99 | 84.21 ± 16.20 | 0.09 |
| Pain reduction after 12 weeks, % (SD) | 83.93 ± 18.59 | 96.96 ± 5.56 | 0.04 |